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Summary Autopsy reports and clinical request forms between March 1973 and September 1986 were
reviewed for patients with a clinical history of breast carcinoma. During this period 85 cases were identified.
The causes of death and metastatic pattern of the breast carcinoma were recorded. Only 25 (29%) of these
patients died as a direct consequence of this disease. Of the 85 cases in total, 28 were thought clinically to
have died as a result of breast carcinoma but autopsy confirmed these findings in only 21 (75%).
Breast carcinoma is reported to be the most common fatal
malignant disease among women in the Western world
(Mould, 1983) yet much is still unknown about its natural
history. Considerable effort has been directed towards
improving diagnosis and treatment but only scant attention
has been paid to the actual cause of death in patients with
this disease. Since 1950, in the English language literature,
only a few autopsy studies, all from American hospitals,
have been reported (Abrams et al., 1950; Meissner &
Warren, 1971; Sproul, 1971; Viadana et al., 1973; Cifuentes
& Pickren, 1979; Cho & Choi, 1980; Hagemeister et al.,
1980; Amer, 1982). It is obviously important that data on
cause of death and presence of residual disease should be
collected to enable realistic comparison of the efficacy of
different modalities of treatment and accurate calculation of
survival times. It was therefore decided to evaluate the
causes of death and ascertain the distribution of residual
disease in breast carcinoma patients autopsied in this
hospital.
Materials and methods
All autopsy records with clinical summaries between March
1973 and September 1986 were reviewed for female patients
with a previous history of breast carcinoma. A total of 85
cases diagnosed and treated before their last admission were
identified. Information regarding histological sub-type of the
neoplasm, non-surgical treatment modalities or menstrual
status was not generally available. Cases where breast cancer
was diagnosed on the patient's last admission or was an
incidental autopsy finding were excluded. A further eight
women who had previously had mastectomies were excluded
from the study as it was not possible to be certain about the
underlying pathology from the records available. None of
these excluded cases had evidence of metastatic breast
disease at autopsy.
The clinical summary accompanying the autopsy request
form and the autopsy findings were considered together to
determine the cause of death in each case. A case was
deemed a breast carcinoma death in the following
circumstances: (1) when extensive metastases were present in
the brain, liver, lung, heart or involved other vital structures;
(2) when the carcinoma was the cause of infection or sepsis;
(3) when the carcinoma was the source of significant
haemorrhage; or (4) When metastatic disease had given rise
to a pulmonary embolus as a result of immobility and deep
venous thrombosis. A non-breast carcinoma death was due
to causes unrelated to breast carcinoma and in the absence
of significant metastatic breast disease. The finding of
occasional small secondary lesions within, for example, the
liver or a lymph node was considered insignificant to the
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cause of death if this was in agreement with autopsy findings
and clinical summaries. Examples of non-breast carcinoma
deaths included myocardial infarction or second primary
malignancies.
All the autopsies were carried out at Ninewells Hospital
and Medical School. In two autopsies the brain was not
removed but these were included in the series as metastatic
brain disease was not suspected clinically. It is usual practice
in this hospital to sample for histology any macroscopic
abnormality and to take a single tissue block from all major
organs. Histology was available in all but two cases. Neither
of these cases had gross evidence of metaststic disease at
post mortem.
Results
A summary ofpatient characteristics is shown in Table I and
survival curves are shown in Figure 1. A review of the
autopsy and clinical findings indicated that only 25 (29%) of
the 85 cases of previously treated breast carcinoma died as a
consequence of the disease. The length of survival of these
patients was significantly shorter (median 31 months as
opposed to 115 months; Mann-Whitney U test, P=0.008)
than that observed in non-breast cancer deaths. The terminal
events in these 25 patients were bronchopneumonia (9 cases),
carcinomatosis (7), pulmonary embolus (5), DIC (1), renal
failure (1), respiratory obstruction (1) and a malignant
pleural effusion (1). In three further cases breast carcinoma
was thought to play a possible role in the patient's death. In
the first case the possibility was raised that systemic
hypertension which had resulted in a subarachnoid
haemorrhage may have been due to secondary breast
carcinoma causing ureteric obstruction. In the second case a
subarachnoid haemorrhage had been precipitated by
Table I Population characteristics
Period of study
Number of autopsied patients
Age at diagnosis
Survival
All patients
Breast carcinoma deaths
Non-breast carcinoma deaths
Site of breast cancer
Left
Right
Bilateral
Surgical treatment
Mastectomy
Bilateral mastectomy
Lumpectomy
Non-surgical treatment
March 1973 to September 1986
85
Mean 60 years (range 31-86)
Median 90 months (range 0-416)
64% five-year survival
Median 31 months (25 cases)
Median 115 months (57 cases)
39
44
2
69
2
2
12
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Table III Major pathology causing death in
succumbing to breast carcinoma
Years
Figure 1 Survival curves for (a) breast carcinoma deaths (25
cases), (b) all patients and (c) non-breast carcinoma deaths (57
cases).
thrombocytopenia as a result of a myeloproliferative disease
which had developed after radiotherapy. In the third case
death was a consequence of disseminated intravascular
coagulation which may have been precipitated by either
radionecrosis of the breast carcinoma or a recent myocardial
infarction.
In 28 patients death was suspected clinically to be a
definite consequence of breast carcinoma. This was correct in
21 (75%) cases with a further case where the breast cancer
may have played a role in the patient's demise. In a further
12 patients the possibility of a breast cancer death was raised
clinically. This was correct in one case, with a further case
where breast carcinoma may have played a role in the
patient's demise. The primary pathology in the cases
suspected clinically to have died of breast carcinoma but
who died from other causes is shown in Table II.
In 43 cases death was thought by the clinicians to have
occurred independent of the patient's breast carcinoma - this
was incorrect in two (5%) cases with a further case where
the disease may indeed have played a role in the patient's
death. In two cases no clinical opinion as to the cause of
death was stated - in one of these death was a result of
metastatic breast disease. Table III lists the cause of death in
all the non-breast cancer deaths.
The incidence of metastases in the various organs of all 85
cases is shown in Table IV. In all cases with metastases the
tumour was of infiltrating 'ductal' type (not otherwise
specified). Of the 57 patients who died of causes unrelated to
breast cancer 15 had evidence of residual disease. Nine of
these had residual breast disease as a result of non-operative
treatment. Three patients had recurrent disease at their
Table II Causes of death in group clinically suspected to
be due to breast cancer but dying of other causes
Cause Number
Myocardial ischaemia 4
Bronchopneumonia 4
Ovarian carcinoma I
Astrocytoma 1
Pneumoccocal meningitis I
Cerebral haemorrhage 1
Small intestinal obstruction (Richter's) I
Peptic ulcer (complications of) I
Pulmonary embolus I
In one case cause of death was uncertain from clinical
and autopsy findings.
patients not
Cause Number
Cardiovascular
Myocardial ischaemia 13
Mitral valve disease (rheumatic)
Congestive cardiac failure (aortic stenosis)
Ruptured aortic aneurysm 1
Respiratory
Bronchopneumonia (not otherwise specified)
Aspergillous bronchopneumonia (bronchiectasis)
Aspergilloma (PMH TB) 1
Acute bronchitis 1
Bronchial carcinoma 3
Carcinoma larynx 1
Chronic obstructive airways disease
Pulmonary embolus 4
Gastrointestinal
Pancreatic carcinoma I
Colonic adenocarcinoma 1
Acute pancreatitis I
Complications of peptic ulceration
Small intestinal obstruction (Richter's hernia)
Genital urinary
Glomerulonephritis 1
Pyelonephritis 2
Adult polycystic kidney disease
Ovarian carcinoma 4
Nervous system
Pneumococcal meningitis 2
Astrocytoma 1
Cerebral haemorrhage 2
Other
Hodgkin's disease 1
Acute myeloid leukaemia 1
Myeloma 1
In one case cause of death was not clear from either autopsy or
clinical summary.
mastectomy sites and sites of metastatic disease included
regional lymph nodes (4 cases), liver (3 cases), lung (2 cases)
and bone (1 case).
Discussion
The reliability of death certification based on clinical
findings is doubtful (Editorial, 1966). In a prospective study
based on 1,152 deaths from all causes, Cameron &
McGoogan (1981) were only able to confirm the major cause
of death clinically in 61% of autopsies. The findings in this
study of patients with treated breast cancer are similar, in
that where a confident clinical diagnosis of a cancer related
death was made autopsy confirmed this in only 75% of the
cases. Moreover, breast cancer was raised as a possible cause
of death in a substantial proportion of patients who were
subsequently found to have died from unrelated causes. With
hindsight some of these cases may have been treatable had it
been possible to form an accurate clinical diagnosis. In
general there seems to be a clinical tendency to over-
diagnose breast cancer as a cause of death when a patient
has been previously treated for this disease. To a much lesser
extent this study has also shown that the occasional breast
cancer death may be missed clinically.
These findings are important, as clinical research
commonly uses mortality statistics in the assessment of
prognostic factors and therapeutic regimes. These studies
often require large numbers of patients to achieve
statistically significant results and this number could possibly
be reduced if accurate mortality statistics based on autopsy
data were available.
An unexpected finding of this study is that only 29% of
the patients with treated breast cancer actually died as a
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Table IV Pattern of metastases in 85 patients (number of cases microscopic in
parentheses)
Number Percentage Previously reported (%)a
Heart 3 (3) 4 5-13
Pericardium 7 (1) 8 19-35
Heart+pericardium 9 (3) 10 22
Lungs 18 (11) 21 57-77
Lungs+pleura 23 (7) 27 75
Gastrointestinal tract 3 4 14-30
Liver 19 22 50-71
Peritoneum 4 (1) 5 13-33
Pancreas 1 1 11-17
Kidneys 2 (1) 2 11-27
Adrenals 4 (2) 5 30-54
Spleen 1 1 11-18
Ovaries 1 (1) 1 12-23
Regional LN 12 14 50-76
General LN 10 (1) 12
Bone 17 20 49-74
Muscle (not local) 1 I
Brain 4 (1) 5 10-36
Meninges 2 2 5-39
Brain+meninges 5 (1) 6 7-31
aAbrams et al., 1950; Meissner & Warren, 1971; Sproul, 1971; Cifuentes &
Pickren, 1979; Cho & Choi, 1980; Hagemeister et al., 1980; Amer, 1982.
direct result of the disease. This is contrary to a figure of
92% found by Hagemeister et al. (1980) and 84% by Cho &
Choi (1980). However, the modes of death (carcinomatosis,
infection, haemorrhage) in the patients who died as a
consequence of breast cancer are similar in all the studies.
This discrepancy in the proportion of patients dying of
breast cancer may result from differences in the nature of
breast cancer or the effectiveness of treatment in the United
Kingdom when compared with the United States of
America. More likely, however, is the possibility that the
figures may be biased and reflect the pattern of autopsy
request by clinicians in different centres rather than the true
mortality experienced by breast cancer patients in general. It
is of interest that the overall survival figures for our 85
patients is comparable with those published in clinical
studies (Gazet, 1981).
These points may also account for the fact that the
incidence of metastases observed in this study are
substantially less than those previously reported (Abrams et
al., 1950; Meissner & Warren, 1971; Sproul, 1971; Cifuentes
& Pickren, 1979; Cho & Choi, 1980; Amer, 1982). However,
it must be stated that none of the previous papers indicated
what proportion of the metastases were microscopic.
Differences in tissue sampling for microscopy between
centres could significantly alter these results. Micro-
metastases, while important in long-term patient prognosis,
are generally of no significance in the immediate cause of
death.
The list of diseases leading to death in those patients
clinically suspected of dying of breast cancer but dying of
independent causes is similar to the list in all non-breast
cancer deaths. This suggests that no particular disease is
likely to mimic breast cancer. However, one particularly
striking feature is the high incidence of a second primary
neoplasm. The significance of this is uncertain but it may be
related to the increasing age of the population with
secondary immunodeficiency, genetic factors or modes of
treatment.
In conclusion this study has highlighted the need for
accurate mortality data in clinical research, treatment and
public health planning and emphasises the need to improve
autopsy rates, which have been falling in this country for
some time. A detailed prospective autopsy study of patients
with breast carcinoma is currently in progress in Tayside.
Information of this type will become particularly important
when mammographic breast screening is introduced in the
near future.
We would like to thank Professor J.S. Beck for his support with this
study.
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